
    
      Retrospective study in CHRU of brest, the investigators selected patient with history of
      méningioma and treated by CYPROTERONE ACETATE, CHLORMADINONE ACETATE and NOMEGESTROL ACETATE
      essentially The investigators excluded patient with risk factor of meningioma added at
      hormonal treatment exposition The investigators discribe the caractéristique of patients:
      age, sex, duration of the treatment, the caractéristique of the meningioma: localization,
      grade, hormonal receptors, treatment by surgery or radiotherapy and changing after
      discontinuation of treatment
    
  